Optimalisation of fluid balance with FlowTrac/Vigileo during the HIPEC procedure

Optimalisation of fluid balance with FlowTrac/Vigileo during the HIPEC procedure - Optifluid

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35708

Enrollment

Registered

2011-09-16

Start date

2011-10-05

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon and ovarium cancer intraperitoneal metastasis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients 18 years and older who require HIPEC procedures

Exclusion criteria

Exclusion criteria: LVEF

Design outcomes

Primary

Measure	Time frame
The primary endpoint is a 30% reduction in the amount of fluid administered during the first 24 hours.	—

Secondary

Measure	Time frame
Secondary endpoints are differences in the number and type of postoperative complications, ventilation and ICU and hospital length of stay, inflammatory response measured by CRP and interleukin values.	—

Countries

Netherlands

Outcome results